Petr Dvořák

5.0k total citations · 1 hit paper
90 papers, 3.4k citations indexed

About

Petr Dvořák is a scholar working on Molecular Biology, Surgery and Biomedical Engineering. According to data from OpenAlex, Petr Dvořák has authored 90 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 14 papers in Surgery and 14 papers in Biomedical Engineering. Recurrent topics in Petr Dvořák's work include Pluripotent Stem Cells Research (37 papers), 3D Printing in Biomedical Research (14 papers) and Fibroblast Growth Factor Research (13 papers). Petr Dvořák is often cited by papers focused on Pluripotent Stem Cells Research (37 papers), 3D Printing in Biomedical Research (14 papers) and Fibroblast Growth Factor Research (13 papers). Petr Dvořák collaborates with scholars based in Czechia, France and United States. Petr Dvořák's co-authors include Aleš Hampl, Ryan Reca, Katarzyna Miękus, Mariusz Z. Ratajczak, Magda Kucia, Janina Ratajczak, Jiřı́ Pachernı́k, Dana Dvořáková, Lívia Eiselleová and Vı́tězslav Bryja and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.

In The Last Decade

Petr Dvořák

90 papers receiving 3.3k citations

Hit Papers

Embryonic stem cell-derived microvesicles reprogram hemat... 2006 2026 2012 2019 2006 400 800 1.2k

Peers

Petr Dvořák
Yen-Sin Ang United States
Kye-Seong Kim South Korea
Majd Zayzafoon United States
Susan Magdaleno United States
Kshitiz Gupta United States
Petr Dvořák
Citations per year, relative to Petr Dvořák Petr Dvořák (= 1×) peers Nicoletta Zini

Countries citing papers authored by Petr Dvořák

Since Specialization
Citations

This map shows the geographic impact of Petr Dvořák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Dvořák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Dvořák more than expected).

Fields of papers citing papers by Petr Dvořák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Dvořák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Dvořák. The network helps show where Petr Dvořák may publish in the future.

Co-authorship network of co-authors of Petr Dvořák

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Dvořák. A scholar is included among the top collaborators of Petr Dvořák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Dvořák. Petr Dvořák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dvořák, Petr, et al.. (2023). Possibilities of Interpreting the Night-to-Day Ratio Specified by 24-Hour Blood Pressure Monitoring. International Journal of Clinical Practice. 2023. 1–11. 1 indexed citations
2.
Pešl, Martin, Šárka Jelínková, Guido Caluori, et al.. (2020). Cardiovascular progenitor cells and tissue plasticity are reduced in a myocardium affected by Becker muscular dystrophy. Orphanet Journal of Rare Diseases. 15(1). 65–65. 5 indexed citations
3.
Jelínková, Šárka, Lenka Marková, Martin Pešl, et al.. (2019). Generation of two Duchenne muscular dystrophy patient-specific induced pluripotent stem cell lines DMD02 and DMD03 (MUNIi001-A and MUNIi003-A). Stem Cell Research. 40. 101562–101562. 5 indexed citations
4.
Váňová, Tereza, Jan Raška, Pavel Babica, et al.. (2018). Freshwater Cyanotoxin Cylindrospermopsin Has Detrimental Stage-specific Effects on Hepatic Differentiation From Human Embryonic Stem Cells. Toxicological Sciences. 168(1). 241–251. 10 indexed citations
5.
6.
Dvořák, Pavel, David Bednář, Lukáš Bálek, et al.. (2017). Computer‐assisted engineering of hyperstable fibroblast growth factor 2. Biotechnology and Bioengineering. 115(4). 850–862. 53 indexed citations
7.
Raška, Jan, Anton Salykin, Lenka Zerzánková, et al.. (2014). Mutation Frequency Dynamics in HPRT Locus in Culture-Adapted Human Embryonic Stem Cells and Induced Pluripotent Stem Cells Correspond to Their Differentiated Counterparts. Stem Cells and Development. 23(20). 2443–2454. 16 indexed citations
8.
Pešl, Martin, Jan Přibyl, Renata Héžová, et al.. (2014). Molecular and Functional Characterization of Uniform-Sized Beating Embryoid Bodies and Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells. Biophysical Journal. 106(2). 565a–565a. 3 indexed citations
9.
Horák, Daniel, Helena Hlídková, Milan J. Beneš, et al.. (2011). Pentapeptide‐modified poly(N,N‐diethylacrylamide) hydrogel scaffolds for tissue engineering. Journal of Biomedical Materials Research Part B Applied Biomaterials. 98B(1). 54–67. 10 indexed citations
10.
Dvořák, Petr, et al.. (2010). Use of the Crustacean Artemia franciscana for Alternative Biotests. Acta Veterinaria Brno. 79(9). S47–S53. 6 indexed citations
11.
Pachernı́k, Jiřı́, Viktor Horváth, Lukáš Kubala, et al.. (2007). Neural Differentiation Potentiated by the Leukaemia Inhibitory Factor through STAT3 Signalling in Mouse Embryonal Carcinoma Cells. Folia Biologica. 53(5). 157–163. 15 indexed citations
12.
Dvořák, Petr, et al.. (2006). Možnosti využití biotestu s Artemia salina při studování toxikologických účinků inhibitorů cyklin-dependentních kináz. 20(2). 62–65. 2 indexed citations
13.
Pachernı́k, Jiřı́, Vı́tězslav Bryja, Milan Ešner, Aleš Hampl, & Petr Dvořák. (2005). Retinoic acid-induced neural differentiation of P19 embryonal carcinoma cells is potentiated by leukemia inhibitory factor.. Physiological Research. 54(2). 257–262. 10 indexed citations
14.
Pachernı́k, Jiřı́, Vı́tězslav Bryja, Milan Ešner, et al.. (2005). Neural differentiation of pluripotent mouse embryonal carcinoma cells by retinoic acid: inhibitory effect of serum. Physiological Research. 54(1). 115–122. 62 indexed citations
15.
Bryja, Vı́tězslav, Jiřı́ Pachernı́k, Pavel Krejčı́, et al.. (2004). The role of p27Kip1 in maintaining the levels of D-type cyclins in vivo. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1691(2-3). 105–116. 21 indexed citations
16.
Bryja, Vı́tězslav, Jiřı́ Pachernı́k, Lukáš Kubala, Aleš Hampl, & Petr Dvořák. (2003). The reverse tetracycline-controlled transactivator rtTA2S-S2 is toxic in mouse embryonic stem cells. annales de biologie animale biochimie biophysique. 43(6). 477–486. 8 indexed citations
17.
Jirmanova, Ludmila, et al.. (1999). O-linked carbohydrates are required for FGF-2-mediated proliferation of mouse embryonic cells. The International Journal of Developmental Biology. 43(6). 555–562. 13 indexed citations
18.
Dvořák, Petr, et al.. (1998). Embryoglycan ectodomains regulate biological activity of FGF-2 to embryonic stem cells. Journal of Cell Science. 111(19). 2945–2952. 1 indexed citations
19.
Dvořák, Petr, et al.. (1995). Expression of paternal and maternal mitochondrial HSP70 family, hsc74, in preimplantation mouse embryos. The International Journal of Developmental Biology. 39(3). 511–517. 7 indexed citations
20.
Dvořák, Petr, et al.. (1993). Characterization of a new porcine differentiation antigen involved in the proliferative response to mitogens. Veterinary Immunology and Immunopathology. 35(3-4). 365–373. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026